ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm

著录项

• 来源
  《Circulation: An Official Journal of the American Heart Association》 |2014年第23期|共2页
• 作者

  Moriarty Patrick M.; Thompson Paul D.; Cannon Christopher P.; Guyton John R.; Bergeron Jean; Zieve Franklin J.; Bruckert Eric; Jacobson Terry A.; Baccara-Dinet Marie T.; Zhao Jian; Pordy Robert; Gipe Daniel;

  展开▼
• 作者单位

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 心脏、血管（循环系）疾病;
• 关键词

  PCSK9; Statins; Cholesterol-lowering drugs; Clinical trials; Lipoproteins;

  机译：PCSK9;他汀类药物;降胆固醇药;临床试验;脂蛋白;